XWXianjie Wen

Xianjie Wen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xianjie Wen has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Hua Liang

    A Department of Anaesthesiology , The First People's Hospital of Foshan and Foshan Hospital of Sun Yat-sen University , Foshan , Guangdong Province , China

    5 shared publications
  • Xingqing Liu

    Second Peoples Hosp Foshan, Weiguo Rd 78, Foshan 528000, Peoples R China

    4 shared publications
  • Hanbing Wang

    C Department of Anesthesiology , The First People's Hospital of Foshan & Foshan Hospital of Sun Yat-sen University , Foshan , Guangdong Province , China

    3 shared publications
  • Heng Li

    Department of Anesthesiology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China

    3 shared publications
  • Hongzhen Liu

    A Department of Anaesthesiology , The First People's Hospital of Foshan and Foshan Hospital of Sun Yat-sen University , Foshan , Guangdong Province , China

    3 shared publications
  • Wu Zhaoxia

    Department of Anesthesiology, The Second School of Clinical Medicine, Southern Medical University, Foshan Second People's Hospital, Foshan, Guangdong Province, China

    3 shared publications

Latest Publications

  • Application of Quantum Dot Multimodal Imaging in Early Disease Diagnosis

    by Zhuohao Bao, Linxin Lu, Jingyi Wang, Haotian Zhu, Xiangliang Dang, Yichao Chen, Xianze Yin, Yiheng Song, Xianjie Wen

    Quantum dot-based multimodal imaging technology provides a highly sensitive and versatile detection approach for early disease screening, demonstrating significant clinical value. This technology simultaneously offers high-sensitivity optical signals, superior tissue penetration depth, and precise anatomical localization, overcoming the inherent limitations of single-modal imaging. This review focuses on the applications and advantages of this technology in early disease screening, particularly highlighting its synergistic applications in fluorescence imaging (enabling high-precision multichannel detection), magnetic resonance imaging (MRI) (where controlled doping strategies facilitate dual-mode contrast enhancement), and computed tomography (CT) (where high-atomic-number quantum dot contrast agents surpass traditional sensitivity limits). Furthermore, the functionalized surface modification of quantum dots enables targeted delivery and therapeutic capabilities, along with artificial intelligence assisted quantum dots data analysis, promoting theranostic integration. Future advancements are expected to further optimize imaging precision and expand clinical applications, offering revolutionary tools for early disease diagnosis with broad development prospects. Graphical Abstract


  • Application and research progress of transparent radiative cooling materials – a review

    by Linxin Lu, Zhuohao Bao, Haotian Zhu, Jingyi Wang, Xiangliang Dang, Yichao Chen, Xianze Yin, Xianjie Wen, Yiheng Song

    Transparent radiative cooling materials with high visible light transmittance and high atmospheric window emissivity.


  • Open Access

    Baicalin Alleviates Neuropathic Pain in Chronic Constriction Injury of the Sciatic Nerve in Mice by the Interferon Regulatory Factor 4/CCL17 Pathway

    by Yun-Lin Wu, Yu-Ting Jiang, Xiao-Jing Ou, Jia-Yi Peng, Zi-Ying Zhou, Xian-Jie Wen

    Objective: The objective of this study was to investigate whether baicalin alleviates neuropathic pain through the interferon regulatory factor 4 (IRF4)/CCL17 pathway in sciatic nerve mice with chronic constriction injury (CCI). Materials and Methods: The experiment was divided into four groups, with eight animals in each group for mechanical withdrawal threshold (MWT) testing and three animals in each group for real-time polymerase chain reaction (PCR), western blot, ELISA, immunohistochemistry and hematoxylin-eosin (HE) testing: wild-type C57BL/6 sciatic nerve ligation group (WT-CCI), C57BL/6 IRF4 −/− sciatic nerve ligation group (KO-CCI), and WT-CCI+baicalin and KO-CCI+baicalin groups. We implemented a CCI of the sciatic nerve model in wild-type and IRF4-knockout mice. MWT was used to test the pain threshold, intumescentia lumbalis was extracted, HE staining was used to observe the infiltration of inflammatory cells in the spinal cord, ELISA was used to detect CCL17 protein expression, immunohistochemistry was used to detect Iba1-positive cells counting, western blotting was used to detect IRF4 protein expression, and real-time PCR was used to detect IRF4 and CCL17 mRNA expression levels. Results: After treatment with baicalin, mice in the WT-CCI+B group showed increased MWT, decreased infiltration of spinal inflammatory cells, decreased Iba1 positive cell count, and decreased expression levels of CCL17 compared to those observed in wild-type CCI mice (WT-CCI group). However, the above indices did not differ between mice in the KO-CCI and KO-CCI+B groups. Conclusions: Baicalin reduced the infiltration of inflammatory cells, inhibited microglial activity, and reduced the expression of the inflammatory mediator CCL17. Baicalin alleviates CCI-induced neuropathic pain involved in the IRF4/CCL17 pathway.


  • Ultrasound-guided intersphincteric space block combined with spinal anesthesia for hemorrhoidectomy: a randomized clinical trial

    by Xiaoxia Liang, Xingqing Liu, Ziyang Lin, Aiwu Luo, Xianjie Wen

    BACKGROUND: We aimed to compare the analgesic effects and incidence of urinary retention between ultrasoundguided intersphincteric space block combined with low -dose ropivacaine spinal anesthesia and conventional -dose ropivacaine spinal anesthesia post-hemorrhoidectomy. METHODS: Fifty patients aged 20-65 years who underwent elective hemorrhoidectomy were stochastically assigned to one of two groups. Spinal anesthesia was induced with 8 mg ropivacaine, combined with ultrasound -guided intersphincteric space block in the treatment group. Spinal anesthesia was induced with 12 mg ropivacaine in the control group. The primary outcome was the postoperative pain score, measured using the Visual Analog Scale (VAS) at 4, 8, 12, 24, and 48 hours and at the first defecation postoperatively. Secondary outcomes included urinary retention, extent of anal sphincter relaxation, and the time required to lift the lower limbs out of bed postoperatively. RESULTS: The treatment group showed markedly lower VAS scores than those of the control group at 8, 12, 24, and 48 h, and at the first postoperative defecation time (P<0.05). The incidence of urinary retention was considerably lower in the treatment group than in the control group (24% vs. 52%, P=0.04). No remarkable difference in the degree of anal sphincter relaxation was observed between the two groups (P=0.556). The time taken by the treatment group patients to lift their lower limbs off the bed was much shorter than that in the control group (1.3 +/- 0.6 h vs. 3.2 +/- 1.2 h, P<0.001). CONCLUSIONS: Ultrasound -guided intersphincteric space block combined with low -dose ropivacaine spinal anesthesia provides good anesthesia and analgesia for hemorrhoidectomy.


  • Open Access

    Retrospective analysis on the efficacy of epidural labor analgesia on early breast feeding after vaginal delivery

    by Xudong Hu, Dongqin Xiong, Meifang Luo, Chen Ling, Xingqing Liu, Kai Yang, Xianjie Wen

    Breastfeeding is essential for infants and mothers. Epidural labor analgesia is used frequently to alleviate pain during vaginal delivery. Studies have found that epidural labor analgesia potentially have negative effects on postpartum breastfeeding. However, the efficacy of epidural labor analgesia on early breastfeeding after vaginal delivery is unclear. Therefore, a retrospective analysis was performed to illuminate the efficacy of epidural labor analgesia on postpartum breast feeding. A total of 392 women who received vaginal delivery in the Second People’s Hospital of Foshan from July 2022 to June 2023 were selected for this study, and all women received epidural labor analgesia and were divided into three groups according to the efficacy of labor analgesia. There were three groups: parturients with VAS scores < 3 were divided into Group E (n = 192), parturients with VAS scores 4–6 were divided into Group M (n = 127), and parturients with VAS scores > 7 were divided into Group P (n = 73). The labor process, lactation initiation time, and incidence of delayed onset of lactation were analyzed. The lactation volume and time and LATCH score at 24, 48 and 72 h after vaginal delivery were also analyzed. There was no significant difference in labor process times among the three groups (P > 0.05). The cases of prolactin use in Group M were less than those in Group E and Group P, with a significant difference (all P < 0.05). There was no significant difference in cases of prolactin use between Group E and Group P (P > 0.05). The lactation initiation time in Group M was significantly shorter than those in Group E and Group P (all P>0.05). There was no significant difference in lactation initiation time after vaginal delivery between Group E and Group P (P>0.05). The incidence of delayed onset of lactation in Group M was significantly lower those that in Group E and Group P (all P < 0.05). There was no statistically significant difference in the incidence of delayed onset of lactation between Group E and Group P (P > 0.05). The lactation volumes at 24, 48 and 72 h after vaginal delivery in Group M were significantly higher than those in Group E and Group P (all P < 0.05). There was no significant difference in lactation volume at 24, 48 and 72 h after vaginal delivery between Group E and Group P (P > 0.05). The lactation times at 24, 48 and 72 h after vaginal delivery in Group M were significantly higher than those in Group E and Group P (all P < 0.05). There was no significant difference in lactation times at 24, 48 and 72 h after vaginal delivery between Group E and Group P (P > 0.05). There was no significant difference in LATCH scores at 24, 48 and 72 h after vaginal delivery among the three groups (all P > 0.05). Compared with labor analgesia with excellent and poor analgesia efficacy, labor analgesia with moderate analgesia efficacy has fewer cases of prolactin use, more lactation volume and time, a shorter lactation initiation time, a lower incidence of delayed onset of lactation and no effect on the LATCH score of breastfeeding.


  • Open Access

    Retrospective analysis of the efficacy of epidural labour analgesia on early breastfeeding after vaginal delivery

    by Xudong Hu, Dongqin Xiong, Meifang Luo, Chen Ling, Xingqing Liu, Xianjie Wen

    Background The breast feeding is important for infant and mother .The epidural labour analgesia is used frequently to alleviate the pain during the vaginal delivery . Studies found that epidural labor analgesia may have a negative effect on postpartum breastfeeding. But the efficacy of epidural labour analgesia on breastfeeding early after vaginal delivery was unclear . So this retrospective analysis was made to illuminate the efficacy of epidural labour analgesia on postpartum breast feeding. Methods 392 women who received vaginal delivery in the Second People's Hospital of Foshan from July 2022 to June 2023 were selected in this studyand all women received the epidural labour analgesia were divide into three group according to the efficacy of labour analgesia. Women with VAS score 4-6 were divided into Group M(n=127) and women with VAS score﹥7 were divided into Group P (n=73).The lactation initiation time and the incidenceof delayed onset of lactation were analyzed .The lactation volume and times and the LATCH score at 24,48 and 72 hours after vaginal delivery were also analyzed. Results The lactation initiation time in Group M was shorter than those in Group E and Group P with statistical significance (All P﹤0.05);There was no significant difference of lactation initiation time after vaginal delivery between Group E and Group P (P﹥0.05). The incidence of delayed onset of lactation in Group M were lower than those in Group E and Group P with statistical significance(All P﹤0.05);There was no statistical significance of the incidence of delayed onset of lactation between Group E and Group P(P﹥0.05).The lactation volume at 24 , 48 and 72 hours after vaginal delivery in Group M were higher than those in Group E and Group P with statistical significance (All P ﹤0.05); There wasno significant difference of lactation volume at 24,48 and 72 hours after vaginal delivery between Group E and Group P(P﹥0.05). The lactation times at 24 , 48 and 72 hours after vaginal delivery in Group M were higher than those in Group E and Group Pwith statistical significance (All,P﹤0.05); There wasno significant difference of lactation times at 24,48 and 72 hours after vaginal delivery between Group E and Group P(P﹥0.05).There was no significant difference of LATCH scores at 24,48 and 72 hours after vaginal delivery among the three groups (All P﹥0.05). Conclusions Compared with labour analgesia with excellent and poor analgesia efficacy, the labouranalgesia with moderate analgesia efficacy has less cases of prolatin using,morelactation volume and times, shorter lactation initiation time, lessincidence of delayed onset of lactation and no effect on the LATCH score of breastfeeding.

  • Open Access

    RNA-seq analysis revealed genes associated with neuropathic pain induced by chronic compressive injury in interferon regulatory factors 4 knockout mice

    by Jiayi Peng, Yunlin Wu, Qi E, Ziyin Zhou, Xianjie Wen

    Objective: To explore the differential expression of genes between wild-type chronic compressive injury (CCI) mice (WT-CCI) and interferon regulatory factors 4 (IRF4) knockout CCI mice (KO-CCI) by RNA-seq analysis of the mouse spinal cord. Methods: RNA-seq analysis of the spinal cord tissue of the chronic sciatic nerve ligation mice and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were used. Results: A total of 104 genes were up-regulated and 116 genes were down-regulated in spinal cord of the mice in IRF4 knockout (KO-CCI) group compared with that in the wild-type CCI (WT-CCI) group. There were 1472 differentially expressed genes in the biological process group, 62 differentially expressed genes in the cellular component group, and 163 differentially expressed genes in the molecular function group in KO-CCI mice. A total of 14 genes related to inflammatory reactions were differentially expressed. Real-time PCR results confirmed that Pparg and Grpr mRNA expression was up-regulated and Arg 1 and Ccl11 mRNA expression was down-regulated in the KO-CCI group. Conclusion: IRF4 is involved in neuropathic pain in CCI mice, IRF4 may participate in neuropathic pain by regulating Grpr, Mas1, Galr3, Nos2, Arg1, Ccl11, Ptgs2, S100a8, Pparg, Cd40, Has2, Gpr151, Il123a, Capns2, Ankrd1, Ccnb1, and Nppb genes.


  • Open Access

    Establishment of an animal model of sciatic nerve injury induced by local anesthetics

    by Qi E, Yunlin Wu, Xiaoxia Liang, Meixin Chen, Jiayi Peng, Ziyin Zhou, Xianjie Wen

    Peripheral neurotoxicity injury caused by local anesthetics is a common complication of clinical anesthesia. The study of its mechanism is helpful to prevent and treat the neurotoxic injury of local anesthetics. Previous studies on peripheral neurotoxicity injury caused by local anesthetics have mainly focused on in vitro cell experiments. Due to the lack of an animal model of peripheral neurotoxicity damage caused by local anesthetics, there are few in vivo experimental studies regarding this topic. Herein, 1% ropivacaine hydrochloride was injected into the sciatic nerve by direct incision and exposure of the sciatic nerve to create a local anesthetic neurotoxic injury model. The results showed that 1% ropivacaine hydrochloride could reduce the lower limb motor score and mechanical paw withdrawal threshold in mice 48 hours after injection. Pathological sections showed that 48 hours after treatment with 1% ropivacaine hydrochloride, the sciatic nerve showed increased axonal edema and degeneration, edema between nerve fiber bundles, increased degeneration of axon and myelin sheath vacuoles, edema of nerve bundle membrane and local degeneration and necrosis, and a large number of inflammatory cells around the nerve adventitia were soaked. The above results show that under open vision, 1% ropivacaine hydrochloride can cause injury to the sciatic nerve after 48 h of treatment, which can simulate the neurotoxic damage of local anesthetics. This animal model provides a research tool for studying the mechanism of neurotoxic injury caused by local anesthetics.